期刊文献+

ICU患者中心静脉导管相关性血流感染病原菌分布及耐药性分析 被引量:10

下载PDF
导出
摘要 目的探讨ICU患者中心静脉导管相关性血流感染(CRBSI)病原菌的分布特点及其耐药性,为临床合理防治CRBSI提供参考依据。方法回顾性分析2008年1月至2012年12月ICU中心静脉留置治疗患者感染的发生情况,并对其痛原菌及耐药特点进行分析。结果共栓出197株病原菌,其中革兰阴性杆菌占48.22%,革兰阳性球菌占40.61%,真菌占11.17%。药敏结果显示,鲍氏不动杆菌和铜绿假单胞菌的耐药率普遍较高;对大肠埃希菌和肺炎克雷伯菌耐药率低的有头孢替坦、哌拉西林/他唑巴坦、头孢哌酮,舒巴坦和阿米卡星,未检出耐亚胺培南菌株;对阳性球菌耐药率低的有利福平和呋喃妥因,未检出耐替加环素、替考拉宁和万古霉素菌株。结论中心静脉留置导管较易引起血流感染,引起血流感染病原菌主要以表皮葡萄球菌和鲍氏不动杆菌为主,且耐药性严重。 Objective To investigate the distribution of pathogen and drug resistance analysis for Catheter-related bloodstream infection ( CRBSI ) in ICU, to provide evidence for the guidance of clinical rational administration CRBSI.Metbods We examined records with catheter- related blood stream infection from Jan. 2008 to Dec. 2012 in ICU, and the pathogens and bacterial resistance research were also included.Results A total of 197 strains of pathogenic bacteria was detected, including gam-negative bacillus ( 48.22% ) , gain-positive cocci ( 40.61% ) and fungus ( 11.17% ) .Drug susceptibility showed the generally higher drug resistance to Acinetobacter aumannii and Pseudomonas aeruginosa. Escherichia coli and Klebsiella pneumonia were sensitive to cefotetan, piperacillin/tazobactam, Cefoperazone/sulbactam, amikacin and imipenem. Gram-positive bacteria were sensitive to rifampicin, nitrofurantoin, tigecycline, teicoplanin and vancomycin. Conclusion Venous terization was easy to cause blood stream infection, Staphylococcus epidermidis and Acinetobacter baumannii were the commonest pathogens and its resistance rate was very high.
出处 《浙江临床医学》 2015年第1期26-27,共2页 Zhejiang Clinical Medical Journal
基金 浙江省台州市科技局基金(2011A33190)
关键词 中心静脉导管 导管相关性血流感染 病原菌 分布 耐药性 Central venous catheter Catheter-related bloodstream infection Pathogen Distribution Drug resistance
  • 相关文献

参考文献8

二级参考文献54

  • 1刘大鹰,谢正福,施焕中,覃雪军,陈强,肖常青.重症监护病房与非重症监护病房中心静脉导管相关感染的对比研究[J].中国呼吸与危重监护杂志,2006,5(3):162-167. 被引量:45
  • 2孙立英,张红鹰,刘坤,杜晓玲.血管内导管相关血流感染的临床分析[J].中华医院感染学杂志,2007,17(6):676-677. 被引量:17
  • 3Valles J, Ferrer R. Bloodstream infection in the ICU. Infect Dis Clin North Am ,2009,23:557-569. 被引量:1
  • 4Digiovine B, Chenoweth C, Watts C, et al. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med, 1999,160:976- 981. 被引量:1
  • 5Warren DK, Quadir WW, Hollenbeak CS, et al. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med,2006,34:2084- 2089. 被引量:1
  • 6Renaud B, Brun-Buisson C, ICU-Bacteremia Study Group. Outcomes of primary and catheter-related bacteremia. A cohort and casecontrol study in critically ill patients. Am J Respir Crit Care Med, 2001,163 : 1584-1590. 被引量:1
  • 7Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control, 2008,36:309-332. 被引量:1
  • 8Suljagic V, Cobeljic M, Jankovic S, et al. Nosocomial bloodstream infections in ICU and non-ICU patients. Am J Infect Control,2005, 33:333-340. 被引量:1
  • 9Harbarth S, Ferriere K, Hugonnet S, et al. Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care. Arch Surg, 2002,137 : 1353-1359. 被引量:1
  • 10Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med, 2001,344 : 699 -709. 被引量:1

共引文献137

同被引文献67

引证文献10

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部